NALOXONE | NALOXONE | ATC V03AB15 ATC A06AH04 ATC N02AA53 ATC N02AA55
VARIOUS ALKALOID NARCOTIC ANTAGONIST ANTINARCOTIC AGENTS DEPRESSANTS OPIATE ANTAGONISTS RELIEF OF MODERATE TO SEVERE PAIN TREATMENT OF OPIOID DEPENDANCE | INJECTION ORAL SUBLINGUAL BUCCAL INTRAMUSCULAR SUBCUTANEOUS NASAL | Cmax 0.85 NANOMOLAR Tmax 0.81 HOUR VD 110.5 LITER (65 KILOGRAM) PPB 45 PERCENT Cl 89.7 LITER / HOUR (65 KILOGRAM) HT 6.25 HOUR SOLUBILITY SOLUBLE IN WATER | MU-TYPE OPIOID RECEPTOR | OPIOID RECEPTORS MU/KAPPA/DELTA ANTAGONIST CHEMBL2095181 OPIOID RECEPTORS MU/KAPPA/DELTA P35372 MU-TYPE OPIOID RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 PEPTIDE SHORT PEPTIDE OPIOID RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |